Role of Semen in HIV-1 Transmission: Inhibitor or facilitator?

American Journal of Reproductive Immunology

Volumn 65, Issue 3, 2011, Pages 292-301

  Doncel, Gustavo F ^a   Joseph, Theresa ^a   Thurman, Andrea R ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

HIV transmission; Inflammation; Mucosal immunity; Semen; Vaginal cells

Indexed keywords

CATIONIC SURFACTANT; CYCLOOXYGENASE 2; DEFENSIN; LACTOFERRIN; POLYPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROSTAGLANDIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANTIVIRAL ACTIVITY; CYTOTOXICITY; DENDRITIC CELL; DEVELOPING COUNTRY; DISEASE TRANSMISSION; EJACULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MULTICENTER STUDY; NONHUMAN; OPSONIZATION; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEMINAL PLASMA; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SPERM; TARGET CELL; UNSAFE SEX; VAGINA; VAGINA DISCHARGE; VAGINITIS; VIRION; VIRUS ATTACHMENT; VIRUS CARRIER; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS TYPING;

DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; MALE; MUCOUS MEMBRANE; SEMEN; VAGINA; VIRUS ATTACHMENT;

EID: 79551632688     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00931.x     Document Type: Review

References (84)

1. UNAIDS: 09 AIDS epidemic update .
2. Hladik F, Hope TJ: HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep 2009; 6:20-28.
3. Shattock RJ, Moore JP: Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003; 1:25-34.
4. Norvell MK, Benrubi GI, Thompson RJ: Investigation of microtrauma after sexual intercourse. J Reprod Med 1984; 29:269-271.
5. Stone M, Ma ZM, Genesca M, Fritts L, Blozois S, McChesney MB, Miller CJ: Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus. Virology 2009; 392:260-270.
6. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM: Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009; 206:1273-1289.
7. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-223.
8. Li N, Chen Y, He W, Yi T, Zhao D, Zhang C, Lin CL, Todorov I, Kandeel F, Forman S, Zeng D: Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI. Blood 2009; 113:953-962.
9. Thurman AR, Doncel GF: Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition. 20678168. Am J Reprod Immunol 2010; doi:. Jul 30 [Epub ahead of print].
10. Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W, Kaul R: Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008; 49:520-522.
11. Swingler S, Easton A, Morris A: Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells. AIDS Res Hum Retroviruses 1992; 8:487-493.
12. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C: Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 1999; 13:823-831.
13. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, Stewart PW, Powers KA, Galvin S, Chilongozi D, Gama S, Price MA, Fiscus SA, Cohen MS: Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007; 21:1723-1730.
14. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Magaret AS, Wang RS, Kidoguchi L, Barnes L, Ridzon R, Corey L, Celum C: Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010; 375:824-833.
15. Lorello G, la Porte C, Pilon R, Zhang G, Karnauchow T, MacPherson P: Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med 2009; 10:548-554.
16. Krieger JN, Nirapathpongporn A, Chaiyaporn M, Peterson G, Nikolaeva I, Akridge R, Ross SO, Coombs RW: Vasectomy and human immunodeficiency virus type 1 in semen. J Urol 1998; 159:820-825. Discussion 825-826.
17. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
18. Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R: Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589-598.
19. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
20. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
21. Klebanoff SJ, Kazazi F: Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system. J Clin Microbiol 1995; 33:2054-2057.
22. Stief TW: Singlet oxygen (1O2)-oxidazable lipids in the HIV membrane, new targets for AIDS therapy? Med Hypotheses 2003; 60:575-577.
23. Agarwal A, Prabakaran SA: Mechanism, measurement, and prevention of oxidative stress in male reproductive physiology. Indian J Exp Biol 2005; 43:963-974.
24. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM: Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991; 164:94-100.
25. Klebanoff SJ, Coombs RW: Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991; 174:289-292.
26. Katz E, Goldblum T, Bachrach U, Goldblum N: Antiviral action of oxidized spermine: inactivation of certain animal viruses. Isr J Med Sci 1967; 3:575-577.
27. Bachrach U, Don S: Inactivation of influenza and Newcastle disease viruses by oxidized spermine. Isr J Med Sci 1970; 6:435-437.
28. Bachrach U, Don S: Inactivation of myxoviruses by oxidized polyamines. J Gen Virol 1971; 11:1-9.
29. Bachrach U, Rosenkovitch E: Effect of oxidized spermine and other aldehydes on the infectivity of vaccinia virus. Appl Microbiol 1972; 23:232-235.
30. Cole AM, Cole AL: Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol 2008; 59:27-34.
31. O'Connor TJ, Kinchington D, Kangro HO, Jeffries DJ: The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro. Int J STD AIDS 1995; 6:267-272.
32. Martellini JA, Cole AL, Venkataraman N, Quinn GA, Svoboda P, Gangrade BK, Pohl J, Sorensen OE, Cole AM: Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 2009; 23:3609-3618.
33. Sabatte J, Ceballos A, Raiden S, Vermeulen M, Nahmod K, Maggini J, Salamone G, Salomon H, Amigorena S, Geffner J: Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 2007; 81:13723-13734.
34. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-597.
35. Galvin SR, Cohen MS: The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42.
36. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, Hendrickx AG: Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia 1. J Virol 1994; 68:6391-6400.
37. Salle B, Brochard P, Bourry O, Mannioui A, Andrieu T, Prevot S, Dejucq-Rainsford N, Dereuddre-Bosquet N, Le Grand R: Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis 2010; 202:337-344.
38. Miller CJ: Use of the SIV/Rhesus Macaque Model of the Heterosexual Transmission of HIV in AIDS Vaccine Research. Vaccine Res 1992; 1:295-301.
39. Politch JA, Mayer KH, Anderson DJ: Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-289.
40. Zacharopoulos VR, Perotti ME, Phillips DM: A role for cell migration in the sexual transmission of HIV-1? Curr Biol 1997; 7:534-537.
41. Pilcher CD, Tien HC, Eron Jr. JJ, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS: Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189:1785-1792.
42. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, Holmes KK: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174:1058-1063.
43. Yamamoto T, Zhou X, Williams CJ, Hochwalt A, Forney LJ: Bacterial populations in the vaginas of healthy adolescent women. J Pediatr Adolesc Gynecol 2009; 22:11-18.
44. Ongradi J, Ceccherini-Nelli L, Pistello M, Specter S, Bendinelli M: Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses 1990; 6:1433-1436.
45. WHO. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th edn, Geneva, Switzerland, WHO, 2010. ISBN 9789241547789.
46. Fox CA, Meldrum SJ, Watson BW: Continuous measurement by radio-telemetry of vaginal pH during human coitus. J Reprod Fertil 1973; 33:69-75.
47. Wolters-Everhardt E, Dony JM, Lemmen WA, Doesburg WH, De Pont JJ: Buffering capacity of human semen. Fertil Steril 1986; 46:114-119.
48. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F: Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131:1059-1071.
49. Wojtowicz WM, Farzan M, Joyal JL, Carter K, Babcock GJ, Israel DI, Sodroski J, Mirzabekov T: Stimulation of enveloped virus infection by beta-amyloid fibrils. J Biol Chem 2002; 277:35019-35024.
50. Collins KA, Bennett AT: Persistence of spermatozoa and prostatic acid phosphatase in specimens from deceased individuals during varied postmortem intervals. Am J Forensic Med Pathol 2001; 22:228-232.
51. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC: Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010; 285:1861-1869.
52. Roan NR, Munch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC: The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 2009; 83:73-80.
53. Toyoshima K, Vogt PK: Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 1969; 38:414-426.
54. Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Munch J: Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010; 7:55.
55. Maher D, Wu X, Schacker T, Horbul J, Southern P: HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci USA 2005; 102:11504-11509.
56. Ceballos A, Remes Lenicov F, Sabatte J, Rodriguez Rodrigues C, Cabrini M, Jancic C, Raiden S, Donaldson M, Agustin Pasqualini Jr R, Marin-Briggiler C, Vazquez-Levin M, Capani F, Amigorena S, Geffner J: Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med 2009; 206:2717-2733.
57. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC: Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010; 285:1861-1869.
58. Neurath AR, Strick N, Li YY: Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infect Dis 2006; 6:150.
59. Patel S, Hazrati E, Cheshenko N, Galen B, Yang H, Guzman E, Wang R, Herold BC, Keller MJ: Seminal plasma reduces the effectiveness of topical polyanionic microbicides. J Infect Dis 2007; 196:1394-1402.
60. Keller MJ, Mesquita PM, Torres NM, Cho S, Shust G, Madan RP, Cohen HW, Petrie J, Ford T, Soto-Torres L, Profy AT, Herold BC: Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials. PLoS ONE 2010; 5:e8781.
61. Bouhlal H, Chomont N, Haeffner-Cavaillon N, Kazatchkine MD, Belec L, Hocini H: Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J Immunol 2002; 169:3301-3306.
62. Robertson SA, O'Leary S, Armstrong DT: Influence of semen on inflammatory modulators of embryo implantation. Soc Reprod Fertil Suppl 2006; 62:231-245.
63. Pandya IJ, Cohen J: The leukocytic reaction of the human uterine cervix to spermatozoa. Fertil Steril 1985; 43:417-421.
64. Thompson LA, Barratt CL, Bolton AE, Cooke ID: The leukocytic reaction of the human uterine cervix. Am J Reprod Immunol 1992; 28:85-89.
65. Lovell JW, Getty R: Fate of semen in the uterus of the sow: histologic study of endometrium during the 27 hours after natural service. Am J Vet Res 1968; 29:609-625.
66. Phillips DM, Mahler S: Leukocyte emigration and migration in the vagina following mating in the rabbit. Anat Rec 1977; 189:45-59.
67. De M, Wood GW: Analysis of the number and distribution of macrophages, lymphocytes, and granulocytes in the mouse uterus from implantation through parturition. J Leukoc Biol 1991; 50:381-392.
68. Tremellen KP, Seamark RF, Robertson SA: Seminal transforming growth factor beta1 stimulates granulocyte-macrophage colony-stimulating factor production and inflammatory cell recruitment in the murine uterus. Biol Reprod 1998; 58:1217-1225.
69. Robertson SA, Ingman WV, O'Leary S, Sharkey DJ, Tremellen KP: Transforming growth factor beta--a mediator of immune deviation in seminal plasma. J Reprod Immunol 2002; 57:109-128.
70. Ludman BG: Human seminal plasma protein allergy: a diagnosis rarely considered. J Obstet Gynecol Neonatal Nurs 1999; 28:359-363.
71. Sharkey DJ, Macpherson AM, Tremellen KP, Robertson SA: Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod 2007; 13:491-501.
72. Berlier W, Cremel M, Hamzeh H, Levy R, Lucht F, Bourlet T, Pozzetto B, Delezay O: Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum Reprod 2006; 21:1135-1142.
73. Lore K, Larsson M: The role of dendritic cells in the pathogenesis of HIV-1 infection. APMIS 2003; 111:776-788.
74. Cremel M, Hamzeh-Cognasse H, Genin C, Delezay O: Female genital tract immunization: evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation. Vaccine 2006; 24:5744-5754.
75. Hladik F, Doncel GF: Preventing mucosal HIV transmission with topical microbicides - challenges and opportunities. Antiviral Res 2010; doi:. [Epub ahead of print].
76. O'Leary S, Jasper MJ, Warnes GM, Armstrong DT, Robertson SA: Seminal plasma regulates endometrial cytokine expression, leukocyte recruitment and embryo development in the pig. Reproduction 2004; 128:237-247.
77. Palm F, Walter I, Budik S, Kolodziejek J, Nowotny N, Aurich C: Influence of different semen extenders and seminal plasma on PMN migration and on expression of IL-1beta, IL-6, TNF-alpha and COX-2 mRNA in the equine endometrium. Theriogenology 2008; 70:843-851.
78. Smith GD, Wolf DP, Trautman KC, da Cruz e Silva EF, Greengard P, Vijayaraghavan S: Primate sperm contain protein phosphatase 1, a biochemical mediator of motility. Biol Reprod 1996; 54:719-727.
79. Maldve RE, Kim Y, Muga SJ, Fischer SM: Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res 2000; 41:873-881.
80. Munir I, Fukunaga K, Kanasaki H, Miyazaki K, Ohba T, Okamura H, Miyamoto E: Expression of cyclooxygenase 2 by prostaglandin E(2) in human endometrial adenocarcinoma cell line HEC-1B. Biol Reprod 2000; 63:933-941.
81. Templeton AA, Cooper I, Kelly RW: Prostaglandin concentrations in the semen of fertile men. J Reprod Fertil 1978; 52:147-150.
82. Sales KJ, Katz AA, Millar RP, Jabbour HN: Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod 2002; 8:1065-1070.
83. Muller M, Sales KJ, Katz AA, Jabbour HN: Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor. Endocrinology 2006; 147:3356-3365.
84. Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN: Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 2007; 22:36-44.